Conditions

Treatments

Autism Spectrum Disorder

Investigational protocols use immunomodulatory MSCs to target the chronic neuro-inflammation and altered immune signalli…

Open →

Diabetes (Type 1 & 2)

MSC protocols aim to modulate the autoimmune attack in type-1 diabetes and improve insulin sensitivity and beta-cell env…

Open →

Multiple Sclerosis

Regenerative protocols pair immunomodulation to calm autoimmune demyelination with neurotrophic support, used alongside …

Open →

Parkinson's Disease

Neural-lineage and MSC protocols aim to support dopaminergic pathways and reduce neuro-inflammation, complementing levod…

Open →

Alzheimer's Disease

MSC and exosome protocols target neuro-inflammation and synaptic support in early-stage cognitive decline, as an adjunct…

Open →

Cerebral Palsy

MSC protocols aim to reduce neuro-inflammation and support motor pathways in children with CP, paired with physiotherapy…

Open →

Spinal Muscular Atrophy

Adjunctive regenerative protocols aim to support motor-neuron environment and muscle function alongside approved gene an…

Open →

Muscular Dystrophy

Protocols aim to modulate inflammation and support the muscle-repair environment in dystrophic muscle, as supportive car…

Open →

Rheumatoid Arthritis

Immunomodulatory MSC protocols aim to dampen the autoimmune inflammation driving joint damage, as an adjunct to DMARDs.…

Open →

Liver Cirrhosis

MSC protocols aim to reduce hepatic inflammation and fibrosis and support residual liver function in compensated disease…

Open →

Anemia

Selected anaemias linked to marrow or immune dysfunction are addressed with supportive cell protocols within a haematolo…

Open →

Arterial Hypertension

Regenerative protocols target endothelial function and vascular inflammation as an adjunct to antihypertensive medicatio…

Open →

Erectile Dysfunction

MSC and exosome protocols aim to regenerate penile vascular and erectile tissue, targeting the underlying vascular cause…

Open →

Male Infertility

Protocols explore regenerative support of testicular function in selected non-obstructive cases, within a fertility-spec…

Open →

Primary Immunodeficiency

Cell protocols are considered within an immunology framework to support immune reconstitution in selected primary immuno…

Open →

Aesthetic & Anti-Ageing

Cell-free exosome and fibroblast protocols target skin quality, regeneration and biological revitalisation for longevity…

Open →

Developmental Cognitive Delay

Investigational protocols aim to support neurodevelopment via neural-lineage and MSC cells, paired with developmental th…

Open →

Knee Osteoarthritis

Intra-articular MSC and chondrocyte protocols aim to reduce joint inflammation and support cartilage in osteoarthritic k…

Open →

Back & Disc Degeneration

Targeted MSC protocols aim to calm inflammation in degenerative discs and facet joints, addressing chronic mechanical ba…

Open →

Peripheral Neuropathy

MSC and neurogenic protocols target the nerve-supporting environment and microvascular damage behind diabetic and idiopa…

Open →

Stroke Recovery

In the recovery phase after stroke, regenerative protocols aim to support neuroplasticity and reduce residual neuro-infl…

Open →

COPD & Lung Disease

Intravenous and nebulised MSC/exosome protocols aim to reduce airway inflammation and support lung tissue in COPD, as an…

Open →

Crohn's & IBD

Immunomodulatory MSC protocols target the autoimmune inflammation driving Crohn's disease and inflammatory bowel disease…

Open →

Lupus (SLE)

MSC protocols aim to re-balance the overactive immune response in systemic lupus, as an adjunct to immunosuppressive the…

Open →

Chronic Kidney Disease

MSC protocols aim to reduce renal inflammation and fibrosis and support residual kidney function in earlier-stage CKD.…

Open →

Hair Loss & Restoration

Exosome and fibroblast scalp protocols aim to revitalise hair follicles and the scalp microenvironment for androgenetic …

Open →

Long COVID

MSC and exosome protocols target the persistent inflammation and immune dysregulation behind long-COVID fatigue and brai…

Open →

European-grade cell therapy, without European prices.

GMP-certified regenerative medicine in the heart of the EU — from €3,000–8,000, a fraction of US or German pricing. Personalised protocols for international patients from 50+ countries.

Free medical review